Novartis CEO cites diabetes as biggest problem
But, for Novartis their next gen diabetes drug, Galvus, won't be resubmitted for approval until mid 2009.
A Drug Maker’s Views of What Ails Health Care - New York Times
Technorati Tags: Novartis, diabetes, Galvus
Comments